CD36 and breast carcinoma: Nevertheless, more studies are needed to unravel, in breast cancer pathogenesis, the mechanism linking oestradiol-regulated MEDA-4 and CD36, specifically its FA-uptake role, given its multifaceted properties of being both pro- and anti-carcinogenic, through a multitude of mechanisms [37].